- Home
- MKTW vs IPA Comparison
MKTW vs IPA Comparison
Compare MKTW & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKTW
- IPA
- Stock Information
- Founded
- MKTW 1999
- IPA 1983
- Country
- MKTW United States
- IPA Canada
- Employees
- MKTW N/A
- IPA N/A
- Industry
- MKTW Computer Software: Prepackaged Software
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- MKTW Technology
- IPA Health Care
- Exchange
- MKTW Nasdaq
- IPA Nasdaq
- Market Cap
- MKTW 23.1M
- IPA 18.9M
- IPO Year
- MKTW N/A
- IPA 2017
- Fundamental
- Price
- MKTW $0.50
- IPA $0.44
- Analyst Decision
- MKTW Buy
- IPA Strong Buy
- Analyst Count
- MKTW 2
- IPA 2
- Target Price
- MKTW $2.50
- IPA $6.00
- AVG Volume (30 Days)
- MKTW 1.3M
- IPA 1.1M
- Earning Date
- MKTW 11-07-2024
- IPA 12-12-2024
- Dividend Yield
- MKTW 8.01%
- IPA N/A
- EPS Growth
- MKTW N/A
- IPA N/A
- EPS
- MKTW 0.13
- IPA N/A
- Revenue
- MKTW $423,378,000.00
- IPA $17,441,886.00
- Revenue This Year
- MKTW N/A
- IPA $4.33
- Revenue Next Year
- MKTW N/A
- IPA $35.64
- P/E Ratio
- MKTW $3.74
- IPA N/A
- Revenue Growth
- MKTW N/A
- IPA 11.21
- 52 Week Low
- MKTW $0.47
- IPA $0.35
- 52 Week High
- MKTW $3.62
- IPA $2.60
- Technical
- Relative Strength Index (RSI)
- MKTW 37.90
- IPA 40.98
- Support Level
- MKTW $0.47
- IPA $0.40
- Resistance Level
- MKTW $0.70
- IPA $0.53
- Average True Range (ATR)
- MKTW 0.06
- IPA 0.07
- MACD
- MKTW -0.01
- IPA 0.00
- Stochastic Oscillator
- MKTW 14.60
- IPA 37.76
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.